San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Biolinq is raising $109,511,762.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Richard Yang played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Biolinq
Biolinq is a startup that has developed a proprietary wearable biosensor platform that is capable of measuring blood level information, without the need to draw blood. We are developing products that are changing the way patients and consumers access information about their body, by making new levels of actionable information readily available. We are dedicated to the personal and professional growth of all our team members and strive to create a positive and creative work environment.

To learn more about Biolinq, visit http://www.biolinq.me/

Contact:
Richard Yang, Chief Executive Officer
510-847-9655
rich@biolinq.me
https://www.linkedin.com/in/yangrichard/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved